Gossamer Bio, Inc. (GOSS) › Net IncomeGossamer Bio, Inc. (GOSS) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$6.77M2018: -$146.97M2019: -$180.31M2020: -$243.36M2021: -$234.00M2022: -$229.38M2023: -$179.82M2024: -$56.53M2025: -$170.37M-$170.37M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$170.37M-201.4%2024-$56.53M+68.6%2023-$179.82M+21.6%2022-$229.38M+2.0%2021-$234.00M+3.8%2020-$243.36M-35.0%2019-$180.31M-22.7%2018-$146.97M-2070.6%2017-$6.77M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share